ARK Genomic Revolution ETF vs Victoria's Secret & Co — how do they compare? ARK Genomic Revolution ETF trades at $44.43, while Victoria's Secret & Co trades at $93.66 (market cap $7.48B). Which is the better fit depends on your goals.
| ARKG | VSXY | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $44.55 | $99.97 |
52-Week Low | $24.02 | $21.34 |
Market Cap | — | $7.48B |
Enterprise Value | — | $10.13B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VSXY trades at $94.6, down 5.37% today but near its 52-week high, with a bullish technical signal and strong support at $93. The company reported Q1 2026 EPS of $0.60, beating expectations, and shows improving net income margins. Analyst consensus is a Buy with a $91 target, while recent news highlights growth through data-driven marketing and international expansion.
Outlook is positive with earnings momentum and international growth, but risks include high valuation (P/E 37.51) and competitive pressures. Investors may find opportunity in continued execution, though margin sustainability and debt levels warrant monitoring.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →